Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy

Triple negative breast cancer (TNBC) is a subtype of breast cancer, with estrogen receptor, human epidermal growth factor receptor 2 and progesterone receptor negative. TNBC is characterized by high heterogeneity, high rates of metastasis, poor prognosis, and lack of therapeutic targets. Now the tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ruoning, Li, Yueyi, Wang, Hang, Qin, Taolin, Yin, Xiaomeng, Ma, Xuelei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894518/
https://www.ncbi.nlm.nih.gov/pubmed/35243562
http://dx.doi.org/10.1186/s43556-022-00071-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894518/
https://www.ncbi.nlm.nih.gov/pubmed/35243562
http://dx.doi.org/10.1186/s43556-022-00071-6

Ejemplares similares